Removing ovaries in patients with breast cancer and BRCA1 mutation may reduce risk of dying from the disease.
TIME (4/24, Sifferlin) reports that research published in JAMA Oncology suggests that “in women who have both breast cancer and the BRCA1 mutation, having surgery to remove the ovaries can significantly lower their risk of dying from the disease.”
The New York Daily News (4/24, Pearson) reports that investigators “looked at the cases of more than 600 women with the BRCA 1 gene mutation who had been diagnosed with stage 1 or 2 breast cancer.” The researchers “found that those who had their ovaries removed at some point following diagnosis were 62% more likely to be living in 20 years than those who did not.”
